International Journal of Clinical Biochemistry and Research
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2394-6369
Online ISSN: 2394-6377
CODEN : IJCBK6
International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Original Article
Author Details :
Volume : 5, Issue : 1, Year : 2018
Article Page : 134-137
https://doi.org/10.18231/2394-6377.2018.0027
Abstract
Diabetes is characterized by chronic hyperglycemia and disturbances of carbohydrate, protein and lipid metabolism. The present study was undertaken to research the association between serum lipid profile, its abnormalities and the increase risk of coronary artery disease. The study compromised of total 60 subjects out of which 30 were diabetic pateints with T2D and 30 healthy indiviuals, both from the age group 35-50 years. The results indicated that there was a considerable increase in the lipid and its parameters.
Keywords: Diabetes mellitus, HDL-c, LDL-c, Lipid profile, Total cholesterol, VLDL-c.
How to cite : Swami S S, Kanhere A M, Swami S C, Role of Lipids in type 2 diabetes mellitus for causation of coronary artery disease. Int J Clin Biochem Res 2018;5(1):134-137
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
